BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38445662)

  • 21. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
    Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
    Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
    Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
    Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage.
    Rubenwolf PC; Otto W; Denzinger S; Hofstädter F; Wieland W; Georgopoulos NT
    World J Urol; 2014 Aug; 32(4):991-7. PubMed ID: 24022233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH
    Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma.
    Volmar KE; Chan TY; De Marzo AM; Epstein JI
    Am J Surg Pathol; 2003 Sep; 27(9):1243-52. PubMed ID: 12960809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced expression of GATA3 predicts progression in non-muscle invasive urothelial carcinoma of the urinary bladder.
    Kamel NA; Abdelzaher E; Elgebaly O; Ibrahim SA
    J Histotechnol; 2020 Mar; 43(1):21-28. PubMed ID: 31551051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nested and microcystic variants of urothelial carcinoma displaying immunohistochemical features of basal-like urothelial cells: an immunohistochemical and histopathogenetic study.
    Mai KT; Hakim SW; Ball CG; Flood TA; Belanger EC
    Pathol Int; 2014 Aug; 64(8):375-81. PubMed ID: 25143125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
    Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
    Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Gui Y; Cai Z
    J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
    Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential expression of GATA-3 in urothelial carcinoma variants.
    Liang Y; Heitzman J; Kamat AM; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2014 Jul; 45(7):1466-72. PubMed ID: 24745616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder.
    Lee H; Jun SY; Lee YS; Lee HJ; Lee WS; Park CS
    Virchows Arch; 2014 Feb; 464(2):213-20. PubMed ID: 24306957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype.
    Yang F; Zhou Q; Meng L; Xing N
    Medicine (Baltimore); 2019 Jul; 98(27):e16009. PubMed ID: 31277094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD44v6 correlates with cell proliferation and cellular atypia in urothelial carcinoma cell lines 5637 and HT1197.
    Kuncová J; Kostrouch Z; Viale M; Revoltella R; Mandys V
    Folia Biol (Praha); 2005; 51(1):3-11. PubMed ID: 15783086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased urothelial cell detection in the primary bladder smooth muscle cell cultures with dual MACS/qRT-PCR approach.
    Genheimer CW; Guthrie KI; Shokes JE; Bruce AT; Quinlan SF; Sangha N; Ilagan RM; Basu J; Burnette T; Ludlow JW
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):184-9. PubMed ID: 20930617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional Analysis of Immunohistochemically Defined Subgroups of Non-Muscle-Invasive Papillary High-Grade Upper Tract Urothelial Carcinoma.
    Jung M; Lee JH; Kim B; Park JH; Moon KC
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges in the pathological reporting of urothelial carcinoma involving prostatic transurethral resection specimens within a single institution.
    Perrino CM; Fichtenbaum EJ; Pohar KS; Zynger DL
    Pathology; 2013 Dec; 45(7):664-9. PubMed ID: 24247624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
    Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
    Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.